Health Care & Life Sciences » Biotechnology | Gilead Sciences Inc.

Gilead Sciences Inc. | Mutual Funds

Mutual Funds that own Gilead Sciences Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total Stock Market Index Fund
32,680,604
2.52%
131,208
0.33%
07/31/2018
Vanguard 500 Index Fund
23,546,437
1.82%
27,336
0.4%
07/31/2018
American Funds Investment Company of America
17,336,591
1.34%
2,386,000
1.43%
06/30/2018
SPDR S&P 500 ETF
14,421,201
1.11%
166,005
0.4%
09/06/2018
Vanguard Institutional Index Fund
12,579,190
0.97%
14,376
0.4%
07/31/2018
Government Pension Fund - Global (The)
11,771,919
0.91%
-1,280,824
0.11%
12/31/2017
PowerShares QQQ Trust
10,886,430
0.84%
-42,532
1.11%
09/05/2018
Dodge & Cox Stock Fund
10,745,612
0.83%
620,000
1.09%
06/30/2018
Parnassus Core Equity Fund
10,740,062
0.83%
0
4.82%
05/31/2018
iShares Nasdaq Biotechnology ETF
10,350,369
0.8%
-135,345
8%
09/06/2018

About Gilead Sciences

View Profile
Address
333 Lakeside Drive
Foster City California 94404
United States
Employees -
Website http://www.gilead.com
Updated 07/08/2019
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. It also offers other pharmaceutical products under the Letairis, Ranexa, AmBisome, and Zydelig brands.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.